FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/106464 [Registered on: 18/03/2026] Trial Registered Prospectively
Last Modified On: 17/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of two pain-relief skin patches after laparoscopic gallbladder surgery 
Scientific Title of Study   Efficacy of transdermal ketoprofen patch vs diclofenac patch in laparoscopic cholecystectomy 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Harshita Parihar 
Designation  PG Resident 
Affiliation  Peoples College of Medical Sciences and Research Centre Bhopal 
Address  Room No 1 Department of Anaesthesiology Peoples Hospital Bhanpur Bhopal

Bhopal
MADHYA PRADESH
462037
India 
Phone  9131839659  
Fax    
Email  harshitaparihar7@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Anupam Pandey 
Designation  Associate Professor Department of Anaesthesiology 
Affiliation  Peoples College of Medical Sciences and Research Centre Bhopal 
Address  Room No 1 Department of Anaesthesiology Peoples Hospital Bhanpur Bhopal

Bhopal
MADHYA PRADESH
462037
India 
Phone  8889480540  
Fax    
Email  docanshu07@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Anupam Pandey 
Designation  Associate Professor Department of Anaesthesiology 
Affiliation  Peoples College of Medical Sciences and Research Centre Bhopal 
Address  Room No 1 Department of Anaesthesiology Peoples Hospital Bhanpur Bhopal


MADHYA PRADESH
462037
India 
Phone  8889480540  
Fax    
Email  docanshu07@rediffmail.com  
 
Source of Monetary or Material Support  
Nil 
 
Primary Sponsor  
Name  Peoples Hospital Bhopal 
Address  Ayodhya Bypass Road Bhanpur Bhopal Madhya Pradesh India 462037 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Harshita Parihar  Peoples Hospital  Room no 1 Department of Anaesthesiology Peoples Hospital Bhanpur Bhopal
Bhopal
MADHYA PRADESH 
9893666588

harshitaparihar7@gmail.com 
Harshita Parihar  Peoples Medical College Bhanpur  Room No 1 Department of Anaesthesiology Peoples Hospital Bhanpur Bhopal Madhya Pradesh 462037 India
Bhopal
MADHYA PRADESH 
09893666588

harshitaparihar7@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Peoples College of Medical Sciences And Research Centre By Pass Road Bhopal 462037 M P Institutional Ethics Commitee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Diclofenac  Patients scheduled for elective laparoscopic cholecystectomy will receive a transdermal diclofenac patch of 100 mg transdermal route applied before the surgery whose effect will be observed for 24 hours. 
Intervention  Ketoprofen   Patients scheduled for elective laparoscopic cholecystectomy will receive a transdermal ketoprofen patch of 30 mg through transdermal route applied before the surgery and will be observed for 24 hours. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Age 18-65 years of either gender.
ASA grade I and II.
Patients undergoing elective laparoscopic abdominal surgeries.
Patient willing to participate in the study. 
 
ExclusionCriteria 
Details  Patient refused to participate in the study
Known allergy to NSAIDs
Chronic pain or long term analgesic use
Renal, hepatic or peptic ulcer disease
Pregnancy or lactation 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   Dates of Birth or day of the Week 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare postoperative pain scores using Visual Analog Scale (VAS) between transdermal ketoprofen patch and diclofenac patch following laparoscopic cholecystectomy for 6 months (24 weeks).  To compare postoperative pain scores using Visual Analog Scale (VAS) between transdermal ketoprofen patch and diclofenac patch following laparoscopic cholecystectomy for 6 months (24 weeks ) 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the time to first rescue analgesic requirement and the total postoperative opioid/analgesic consumption within the first 24 hours  upto 24 hours 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   After ethical approval and informed consent, adult ASA I-II patients will be scheduled for elective laparoscopic cholecyctectomy will be randomly allocated into two groups. Group K will receive a transdermal ketoprofen patch and Group D a transdermal diclofenac patch applied before the surgery. All patients will undergo standardized general anesthesia. Postoperative pain will be assessed using VAS at predetermined intervals for 24 hours. Rescue analgesia will be given as required and recorded. Data will be analyzed to compare pain scores. 
Close